Molecular landmarks of tumor hypoxia across cancer types.

被引：0

作者：

Bhandari, Vinayak ^{[1
]}

Hoey, Christianne ^{[1
]}

Liu, Lydia ^{[2
]}

Lalonde, Emilie ^{[1
]}

Ray, Jessica ^{[1
]}

Livingstone, Julie ^{[2
]}

Lesurf, Robert ^{[2
]}

Shiah, Yu-Jia ^{[2
]}

Vujcic, Tina ^{[3
]}

Huang, Xiaoyong ^{[3
]}

Espiritu, Shadrielle M. G. ^{[2
]}

Heisler, Lawrence E. ^{[2
]}

Yousif, Fouad ^{[2
]}

Huang, Vincent ^{[2
]}

Yamaguchi, Takafumi N. ^{[2
]}

Yao, Cindy Q. ^{[2
]}

Sabelnykova, Veronica Y. ^{[2
]}

Fraser, Michael ^{[2
]}

Chua, Melvin L. K. ^{[4
]}

van der Kwast, Theodorus ^{[5
]}

Liu, Stanley K. ^{[1
]}

Boutros, Paul C. ^{[6
]}

Bristow, Robert G. ^{[1
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] Ontario Inst Canc Res, Toronto, ON, Canada

[3] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[4] Natl Canc Ctr Singapore, Singapore, Singapore

[5] Univ Hlth Network, Toronto, ON, Canada

[6] Univ Calif Los Angeles, Los Angeles, CA USA

来源：

CLINICAL CANCER RESEARCH | 2021年 / 27卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

IA-018

引用

页数：1

共 50 条

[21] Comparison of biomarkers among 34855 GI cancer samples shows heterogeneity of tumor types.
Dawood, Shaheenah
MEDICINE, 2020, 99 (24)
[22] Genomic landscape of defective DNA damage response and repair mechanisms (DDR) across cancer types.
Teo, MinYuen
Zabor, Emily Craig
Iyer, Gopa
Bambury, Richard
Boyd, Mariel Elena
Rosenberg, Jonathan E.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[23] Measuring intratumoral heterogeneity with a mutant-allele frequency score across distinct cancer types.
Masotti, Cibele
Santos, Filipe F.
Camargo, Anamaria A.
Galante, Pedro A. F.
CLINICAL CANCER RESEARCH, 2018, 24 (01) : 96 - 97
[24] Identification of neutral tumor evolution across cancer types
Williams, Marc J.
Werner, Benjamin
Barnes, Chris P.
Graham, Trevor A.
Sottoriva, Andrea
NATURE GENETICS, 2016, 48 (03) : 238 - 244
[25] Identification of neutral tumor evolution across cancer types
Marc J Williams
Benjamin Werner
Chris P Barnes
Trevor A Graham
Andrea Sottoriva
Nature Genetics, 2016, 48 : 238 - 244
[26] Incidence of ERBB gene fusions (EGFR, ERBB2, ERBB4) across tumor types.
Schubert, Laura
Elliott, Andrew
Doebele, Robert Charles
Lou, Emil
Borghaei, Hossein
Demeure, Michael J.
Kurzrock, Razelle
Le, Anh T.
Reuss, Joshua E.
Ou, Sai-Hong Ignatius
Braxton, David R.
Thomas, Christian A.
Darabi, Sourat
Korn, Wolfgang Michael
El-Deiry, Wafik S.
Liu, Stephen V.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[27] Characterizing telomerase reverse transcriptase (TERT) promoter mutations (mut) across sex, race, and cancer types.
El Zarif, Talal
Machaalani, Marc
Nawfal, Rashad
Xie, Wanling
Choueiri, Toni K.
Pomerantz, Mark
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[28] A comprehensive literature review and meta-analysis on prevalence of BRCAm, HRRm and HRD plus across tumor types.
Shao, Changxia
Wan, Jun
Tang, Huilin
Marley, Andrew
Miller, Chelsey
Brown, Madeline
Song, Yiqing
Han, Jiali
Adeboyeje, Gboyega
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[29] A comprehensive landscape of BRCA1 versus BRCA2 associated molecular alterations and survival outcome across 35 cancer types.
Puccini, Alberto
Xiu, Joanne
Heeke, Arielle Lutterman
Seeber, Andreas
Goldberg, Richard M.
El-Deiry, Wafik S.
Liu, Stephen V.
Sammons, Sarah
Lou, Emil
Philip, Agop Philip
Marshall, John
Shields, Anthony Frank
Lenz, Heinz-Josef
Herzog, Thomas J.
Korn, W. Michael
Salem, Mohamed E.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[30] Multi-tumor-arrays for amplification detection in multiple different tumor types.
Schraml, P
Kononen, J
Bubendorf, L
Moch, H
Bissig, H
Leighton, S
Mihatsch, M
Kallioniemi, A
Kallioniemi, OP
Sauter, G
LABORATORY INVESTIGATION, 1999, 79 (01) : 194A - 194A

← 1 2 3 4 5 →